Riskonnect Named One of The UK's Best Workplaces for Wellbeing™
This honour follows Riskonnect's certification as a Great Place to Work® in the United Kingdom for the fourth year in a row and its naming as one of the UK's Best Workplaces for Development™ earlier this year.
"Riskonnect's recognition as one of the UK's Best Workplaces for Wellbeing™ reinforces the strong culture we have built,' said Kevin Crow, chief human resources officer at Riskonnect. 'We genuinely prioritize our people's health and happiness, supporting wellbeing both in and outside of work. When employees feel balanced, supported, and valued, they bring greater focus, care, and energy to their work — and that helps our customers confidently transform the way they manage risk.'
The Best Workplaces for Wellbeing™ list celebrates companies that consistently place employee wellbeing at the heart of their culture. The ranking is based on employee surveys, which assess fundamental facets of employee wellbeing, including work-life balance, sense of fulfilment, job satisfaction, and financial security.
'A thriving workplace culture is rooted in trust, pride, camaraderie, and a genuine commitment to employee wellbeing. As we mark the fourth year of the UK's Best Workplaces for Wellbeing™ list, we're proud to celebrate organisations that go above and beyond to support their people's mental, physical, financial, and social health. When employees feel truly valued and supported, they're not only healthier – they're also more energised, motivated, and aligned with their organisation's goals. Congratulations to Riskonnect on earning a well-deserved place on this prestigious list," said Benedict Gautrey, managing director of Great Place To Work® UK.
Please see here for more information on Riskonnect and current employment opportunities.
About Riskonnect
Riskonnect is the leading integrated risk management software solution provider. Our technology empowers organisations with the ability to anticipate, manage, and respond in real time to strategic and operational risks across the extended enterprise.
More than 2,700 customers across six continents partner with Riskonnect to gain previously unattainable insights that deliver better business outcomes. Riskonnect has more than 1,500 risk management experts in the Americas, Europe, and Asia-Pacific. To learn more, visit riskonnect.com.
About Great Place To Work®
Great Place To Work® is the global authority on workplace culture. Our mission is to help every place become a great place to work for all. We give leaders and organisations the recognition and tools to create a consistently and overwhelmingly positive employee experience, fostering cultures that are proven to drive business, improve lives, and better society. Our recognition is the most coveted and respected in the world for elevating employer brands to attract the right people. Our proprietary methodology and platform enables organisations to truly capture, analyse, and understand the experience of all employees. Our groundbreaking research empowers organisations to build cultures that retain talent and unlock the potential of every employee. Our coaches, content, and community connect the boldest leaders, ideas, and innovations in employee experience. Since 1992, our Certification™, Best Workplaces™ Lists, and global benchmarks have become the industry standard, built on data from more than 100 million employees in 150 countries around the world. For more information, visit www.greatplacetowork.co.uk.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
an hour ago
- Business Upturn
Gluco6 Recognized for Strong Ingredient Transparency and OTC GLUT-4 Nutritional Support
AUSTIN, July 03, 2025 (GLOBE NEWSWIRE) — SECTION 1 – INTRODUCTION As interest in blood sugar health continues to expand across both clinical and non-clinical audiences, consumers are increasingly turning to nutrition science for new pathways to glucose management. Search trends show a growing curiosity in natural approaches to support healthy glucose levels, with a notable emphasis on metabolic flexibility, energy balance, and insulin sensitivity. In 2025, keywords such as 'natural blood sugar support,' 'GLUT-4 receptor,' and 'glucose stability' have gained momentum across digital wellness communities, reflecting a broader shift away from purely pharmaceutical solutions. The challenges of maintaining balanced blood sugar have become a frequent topic in wellness forums, with individuals expressing concerns around post-meal energy crashes, insulin spikes, and fatigue. At the same time, attention has turned to the underlying mechanisms—such as GLUT-4 receptor activity and metabolic responsiveness—as potential targets for support through diet and lifestyle. This shift has driven interest in ingredient-based interventions that are free of synthetic compounds, caffeine, or habit-forming additives. In response to this emerging demand, non-synthetic formulations with scientifically recognized plant-based ingredients have begun to gain visibility. Positioned at the intersection of transparency, innovation, and holistic health, Gluco6 represents part of this evolution in how the market approaches nutritional support for blood sugar metabolism. Further details about the formulation and ingredient sourcing can be found on the official informational platform SECTION 2 – PRODUCT/COMPANY UPDATE Gluco6, a plant-based glucose support formula, has released its latest ingredient update and formulation positioning for 2025, aligned with evolving consumer awareness around GLUT-4 receptor activity and non-synthetic pathways for managing blood sugar fluctuations. The formula, originally introduced as part of a broader push toward integrative glucose balance, now emphasizes its focus on GLUT-4 modulation—a mechanism supported by a growing body of nutritional and academic research. Unlike conventional formulations that often rely on stimulants or short-term glycemic suppression, Gluco6 positions itself as a wellness-aligned system built around the regulation of glucose transport pathways. At the center of this formula is Sukre™, a functional compound featured for its supportive interaction with GLUT-4 receptors, which play a critical role in the transport of glucose into muscle and fat cells. The 2025 update clarifies that Gluco6 is not intended to treat or cure any medical condition but serves as an informational approach to exploring non-clinical nutritional support. Developed without genetically modified ingredients, artificial stimulants, or synthetic additives, the Gluco6 formula also incorporates a blend of Mediterranean-sourced botanicals and micronutrients. The goal is to address consumer interest in formulations that prioritize purity, sustainability, and accessibility, without requiring prescription intervention. As of 2025, Gluco6 has expanded public-facing documentation to reinforce transparency in sourcing, ingredient disclosure, and alignment with trends in clean-label supplement development. The product update also includes a reaffirmation of the company's neutral wellness positioning—focusing on how nutritional strategies may support the body's natural glucose metabolism without implying outcomes or clinical effects. This update reflects Gluco6's continued alignment with current consumer behavior: seeking proactive, educational, and ingredient-based approaches to metabolic health. SECTION 3 – CONSUMER TREND OVERVIEW Throughout 2024 and into 2025, online search trends related to blood sugar balance have increasingly favored terms rooted in lifestyle wellness and plant-based support. Interest in phrases such as 'GLUT-4 function,' 'natural glucose regulation,' and 'non-synthetic blood sugar supplement' has reflected a cultural pivot toward metabolic autonomy—where individuals seek solutions that align with personal health goals without relying solely on pharmaceutical interventions. Public forums and wellness communities have observed a notable increase in discussions surrounding the mechanisms that influence glucose uptake, including insulin sensitivity, cellular transport pathways, and the role of nutrient timing. Central to these conversations is the GLUT-4 receptor, a protein that facilitates the movement of glucose into cells and has become a focal point for metabolic research and consumer inquiry alike. Gluco6's emergence into this environment corresponds with these heightened awareness levels. Rather than offering direct claims or prescriptive messaging, Gluco6 aligns with the growing preference for ingredient transparency and educational framing. Its inclusion of GLUT-4-supportive elements responds to the elevated attention this receptor has received in peer-reviewed studies and lifestyle research. In particular, consumers seeking to stabilize energy levels throughout the day—without the highs and lows associated with unregulated blood sugar—have shown interest in formulas that integrate metabolic adaptogens, antioxidant-rich botanicals, and bioavailable nutrients. These consumers often express a desire for plant-based formulations that can fit into daily routines without dependency or disruption. Gluco6's update positions the product within this narrative, offering a formulation that speaks to educated buyers interested in the intersection between nutritional science and non-clinical wellness. As digital content around metabolic flexibility and insulin response continues to rise, products that approach glucose management from a holistic, research-aware standpoint are seeing increased visibility in search engines and across peer-led platforms. To explore the full ingredient profile and supporting documentation, visit the official Gluco6 resource page. SECTION 4 – INGREDIENT SPOTLIGHT The Gluco6 formulation is centered around six ingredients selected for their alignment with contemporary wellness discussions surrounding non-synthetic blood sugar support. Each ingredient in the formula has been highlighted in academic literature or traditional nutrition systems for its potential to interact with metabolic processes in a non-clinical, supportive capacity. Sukre™ Sukre is positioned as a functional compound designed to work in harmony with the body's GLUT-4 transport mechanisms. As public interest grows around the role of cellular glucose transporters, Sukre has been referenced in emerging nutrition science as a compound that may complement healthy metabolic signaling. Gluco6 emphasizes Sukre as a core feature of its non-synthetic positioning, distinguishing it from traditional glucose-lowering agents that rely on acute suppression. TeaCrine® (Theacrine) Derived from Chinese tea leaves, TeaCrine is included in the Gluco6 formulation as a source of non-stimulant plant alkaloids. In various nutrition-focused publications, TeaCrine has been explored for its relationship with energy and focus without the involvement of caffeine. While not intended to produce clinical outcomes, its inclusion supports interest in plant-derived adaptogens. Gymnema Sylvestre A botanical with longstanding traditional use, Gymnema has been studied for its interaction with glucose perception and dietary habits. Often featured in educational content surrounding carbohydrate metabolism, Gymnema's presence in Gluco6 reflects a broader return to botanical heritage within modern supplement design. Chromium Recognized as an essential trace element, Chromium has been frequently mentioned in relation to insulin sensitivity and glycemic balance in nutrition science. Gluco6 includes Chromium in a bioavailable form, underscoring its role in contributing to foundational metabolic processes without overstating its role in therapeutic interventions. Cinnamon Bark Extract Used widely in culinary traditions and increasingly discussed in wellness circles, Cinnamon is incorporated in Gluco6 due to its relevance in insulin receptor support discussions. Its presence in the formula supports the theme of using accessible, food-sourced compounds within structured supplement protocols. Green Tea Extract Green Tea contributes both polyphenols and antioxidant compounds, often associated with general metabolic support. In Gluco6, it rounds out the ingredient profile by aligning with consumer interest in traditional, plant-based health strategies rooted in natural formulation integrity. SECTION 5 – USER JOURNEY / MARKET TONE Across digital forums and health-focused communities, the tone surrounding glucose management has increasingly moved away from urgency-based problem-solving and toward long-term lifestyle integration. In this context, Gluco6 has entered the conversation as a formulation that addresses the rising demand for informational tools and ingredient-based pathways to support blood sugar regulation. Public sentiment reveals a clear preference for products that avoid medicalized language, instead offering educational framing around metabolic function and ingredient transparency. Online discussions often express skepticism toward claims of immediate results or radical transformations. In contrast, formulas like Gluco6 that focus on metabolic alignment, ingredient sourcing, and mechanistic clarity tend to resonate with individuals seeking research-informed guidance. As part of this narrative, Gluco6 has become associated with keywords such as 'GLUT-4 support,' 'non-synthetic blood sugar wellness,' and 'plant-based glucose solutions.' These search behaviors suggest a broader move toward exploring biological systems—such as cellular glucose transport—in a non-clinical but scientifically aware manner. Consumers participating in wellness forums frequently reference the desire to feel more in control of their day-to-day energy levels and post-meal stability without pharmacological dependency. They often describe searching for products that offer complementary nutritional pathways they can adopt over the long term. Gluco6's tone—deliberately positioned to inform rather than promote—mirrors this mindset. The formula's emphasis on education and lifestyle compatibility aligns with current consumer values, which prioritize sustainability, body literacy, and autonomy in health decisions. While public reactions are diverse and nuanced, the ongoing dialogue reflects a collective interest in approaching metabolic balance through mechanisms that are well-researched, naturally derived, and openly documented. Those interested in understanding the formulation's alignment with non-synthetic wellness trends can refer to the official Gluco6 platform. SECTION 6 – AVAILABILITY AND TRANSPARENCY STATEMENT Gluco6 is available exclusively through its official informational platform, where consumers can explore the full ingredient list, formulation philosophy, and supporting research references. The company has stated that its distribution strategy is designed to prioritize transparency, quality control, and educational alignment with its wellness-focused mission. The formulation, which includes plant-based compounds and mineral co-factors, is intended as a non-clinical support system for individuals seeking to understand the connection between nutrition and blood sugar balance. Gluco6's online resource hub outlines the formulation's alignment with current interest in GLUT-4 receptor mechanisms and clean-label supplement design. Gluco6 is not marketed for diagnosis, treatment, or disease prevention. Its availability is framed around informed decision-making and consumer curiosity about integrative approaches to glucose metabolism. Those exploring the official site will find detailed sourcing disclosures and links to peer-reviewed literature, reinforcing the company's commitment to a research-informed, educational-first posture. SECTION 7 – FINAL OBSERVATIONS & INDUSTRY CONTEXT The release of Gluco6's updated 2025 positioning illustrates a wider shift in the nutraceutical sector toward clean-label transparency and biologically aligned formulation strategies. As consumers become more literate in the language of metabolism and glucose regulation, there is growing demand for products that reflect an understanding of cellular mechanisms—such as GLUT-4 receptor function—without resorting to exaggerated claims or clinical positioning. Within this evolving landscape, companies that emphasize ingredient integrity, sustainability, and scientific relevance are seeing greater engagement. The industry is increasingly guided by consumer expectations around education-first marketing, non-synthetic ingredient profiles, and sourcing disclosures. These trends are mirrored by increased online traffic for topics like 'natural blood sugar solutions,' 'plant-based glucose support,' and 'glucose metabolism supplements.' Gluco6's 2025 formulation strategy aligns with this new model of supplement development, in which consumer trust is cultivated through clarity, research alignment, and responsible communication. Rather than framing its product as a solution to a medical problem, the company presents Gluco6 as part of an ongoing exploration into how nutrition science can support the body's innate regulatory systems. This approach reflects an industry-wide trend: prioritizing science-backed, naturally derived compounds that integrate into everyday routines without overstating function. As consumer literacy deepens and regulatory scrutiny increases, Gluco6 represents one example of how wellness-aligned products are adapting to new expectations in both content and delivery. SECTION 8 – PUBLIC COMMENTARY THEME SUMMARY In ongoing public forums and digital health communities, Gluco6 has emerged as part of a broader conversation around non-synthetic blood sugar support, drawing a range of responses that highlight both interest and scrutiny. Among recurring discussion points, many participants have noted the formula's focus on GLUT-4 receptor pathways as a distinguishing element, particularly given the increasing awareness around cellular glucose transport in metabolic wellness contexts. Some users have expressed curiosity about the inclusion of lesser-known compounds such as Sukre™, citing interest in how this ingredient fits into emerging nutritional science. Others have pointed to the presence of familiar ingredients—like Cinnamon, Chromium, and Green Tea—as aligning with existing wellness preferences for natural, food-based compounds. A recurring theme in positive commentary centers around the non-stimulant profile of the formula. Consumers who prioritize energy regulation without caffeine or dependency have referenced this as a potential alignment with their values. Transparency in ingredient sourcing and documentation has also been identified as a favorable trait, especially among those seeking clarity in wellness product selection. At the same time, some public sentiment remains cautiously observational. Individuals exploring glucose support options often raise questions about long-term integration, expected timelines for perceived effects, and how formulas like Gluco6 should be interpreted within the context of dietary and lifestyle change. This underscores a broader pattern in health discussions—where skepticism and education coexist as consumers navigate an increasingly complex wellness market. These public conversations reflect a nuanced reception that values transparency, biological alignment, and clear communication. While interest in the GLUT-4 mechanism is growing, the broader dialogue continues to emphasize the importance of framing nutritional products as part of a holistic, informed approach to metabolic balance. ABOUT THE COMPANY Gluco6 was developed as part of a broader initiative to provide consumers with transparent, research-aligned nutritional formulas focused on metabolic wellness. The company's mission is to support individuals seeking non-synthetic pathways to manage energy, blood sugar stability, and overall well-being through informed supplementation. By emphasizing ingredient traceability, scientific context, and clean-label formulation practices, Gluco6 contributes to a growing category of supplements positioned at the intersection of education and daily health support. The company does not offer medical advice or therapeutic services and does not market its products for the treatment, prevention, or diagnosis of disease. Its offerings are intended for informational and wellness-aligned purposes only. CONTACT: Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash
Business Upturn
an hour ago
- Business Upturn
PhenQ Updates 2025 Formula With Strongest OTC Appetite Suppressant Profile and Clinically Studied Craving Support Ingredients
Austin, July 03, 2025 (GLOBE NEWSWIRE) — Section 1 – Introduction As public discourse around weight management increasingly centers on metabolic wellness and lifestyle sustainability, interest in ingredient transparency and multi-pronged dietary support has grown significantly. Search trends across wellness communities indicate a shift from short-term diet strategies to long-view approaches that integrate energy regulation, appetite balance, and metabolic efficiency. Consumers are more likely to seek out formulas that address more than one aspect of weight control—especially those that avoid extreme stimulant profiles or single-function targeting. This behavioral shift has coincided with broader public interest in natural compounds supported by nutritional research, such as amino acids, botanicals, and metabolism-supporting minerals. In particular, ingredients that can be framed within the context of thermogenesis, satiety, and nutritional synergy are gaining traction. As a result, consumer demand continues to evolve toward formulations that offer multi-targeted mechanisms using non-synthetic, generally recognized as safe (GRAS) compounds. In response to these developments, formulations that were once labeled 'fat burners' are being reevaluated under broader criteria—namely, how they fit into non-clinical, whole-body support frameworks without promising weight loss as a singular outcome. Brands operating in this space are adjusting messaging and formulation strategies to meet heightened scrutiny around claims, sourcing, and ingredient function transparency. For more information about PhenQ's updated formulation and full ingredient profile, visit the official website Section 2 – Product Announcement or Update PhenQ has announced an updated 2025 formulation of its non-prescription weight management system, designed to align with shifting consumer expectations for ingredient integrity and multi-mechanism nutritional support. This latest version of the product reinforces its core structure around five key wellness pathways: thermogenic activation, fat storage moderation, appetite regulation, mood support, and metabolic energy balance. The proprietary blend remains anchored by α-Lacys Reset®, a patented compound combining alpha-lipoic acid, magnesium, and cysteine base. Recent research continues to frame this ingredient as a catalyst for thermogenic activity and metabolic responsiveness, without relying on excessive stimulant content. The brand's decision to retain α-Lacys Reset® underscores a science-forward approach to addressing metabolic function using nutritionally supported compounds. Additional adjustments to the formulation include expanded concentrations of traditional metabolism-assisting agents such as Capsimax® powder, natural caffeine, and chromium picolinate. These ingredients have remained popular within weight management circles not for their standalone impact, but for their role within comprehensive nutritional strategies that prioritize satiety, energy production, and micronutrient replenishment. The updated formulation also introduces InnoSlim®, a patented blend of ginseng and astragalus, which is gaining visibility for its role in supporting glucose metabolism and carbohydrate absorption. Together with iodine, B-vitamins, and L-carnitine fumarate, these additions provide nutritional diversity intended to complement modern wellness habits without necessitating disruptive lifestyle changes. PhenQ continues to frame its positioning within the non-clinical category, emphasizing that its formulation is not a treatment protocol but rather a supportive approach to general metabolic wellness. In line with current market preferences, the updated product contains no synthetic fat-blockers, no hormonal agents, and no ingredients classified as controlled substances. It is manufactured in GMP-certified facilities in the U.S. and U.K., using raw materials that meet quality assurance and regulatory thresholds applicable to the nutritional supplement category. This update reflects PhenQ's broader effort to participate in the global transition toward transparent, non-promissory wellness solutions that emphasize functional synergy over one-dimensional outcomes. Section 3 – Consumer Trend Overview Over the past several years, consumer search behavior surrounding weight management supplements has steadily migrated toward holistic, ingredient-conscious products. This shift reflects a broader interest in addressing multiple factors influencing body composition, such as appetite cues, metabolic output, and emotional resilience during calorie-restricted phases. Data drawn from digital wellness communities, search engine queries, and public forums suggest that buyers are placing greater emphasis on transparency and ingredient credibility than on dramatic claims or isolated outcomes. As skepticism grows toward overstated weight loss advertisements, conversations have increasingly focused on understanding what individual ingredients do within the broader context of metabolism. This includes a move away from traditional fat-burning stimulants toward botanical compounds and cofactor nutrients that support the body's natural energy processes without pushing physiological extremes. One emerging theme within consumer discourse is the demand for formulas that consider long-term sustainability. For instance, users are more likely to engage with products that support thermogenesis, mood balance, and fatigue reduction as part of a lifestyle plan rather than isolated 'quick fixes.' These preferences are especially prominent among wellness-oriented audiences who value dietary autonomy, ingredient traceability, and scientific support over trend-based marketing. PhenQ's 2025 update appears aligned with these evolving expectations. The decision to highlight ingredient functionality—without centering outcomes or guarantees—places it within the emerging category of non-clinical metabolic support formulations. Rather than categorizing weight management through a purely physical lens, the updated structure acknowledges psychological and behavioral components such as cravings, motivation, and energy consistency. This trend-centric positioning avoids reliance on transactional language and instead contributes to a more nuanced public understanding of how multi-mechanism supplements may complement existing wellness routines. As more consumers seek out metabolic support rooted in credible nutrition science, the demand for well-rounded, stimulant-moderated solutions is expected to continue growing. Consumers seeking detailed ingredient sourcing, manufacturing practices, and research references may visit official website for additional information. Section 4 – Ingredient or Technology Spotlight The 2025 PhenQ formulation is structured around a series of recognizable and increasingly studied natural ingredients, each selected for its contribution to multi-pathway metabolic support. Central to the formula is α-Lacys Reset®, a patented compound combining alpha-lipoic acid (ALA), magnesium, and cysteine base. This ingredient has been examined in placebo-controlled clinical contexts for its potential to activate thermogenesis and influence body composition markers within the parameters of non-prescription supplementation. α-Lacys Reset® is joined by Capsimax® powder, a highly bioavailable form of concentrated capsaicinoids derived from chili peppers. Research surrounding this ingredient highlights its role in increasing thermogenic efficiency and metabolic expenditure, while also providing digestive tract tolerance compared to raw pepper extracts. Its use has become widespread in formulations that seek to support heat production without relying on high doses of stimulants. Another key component is chromium picolinate, a trace mineral with a long-standing presence in dietary supplements. While not associated with weight loss as a standalone agent, chromium is often cited in nutrition literature for its involvement in glucose metabolism and its reported influence on carbohydrate-related cravings. Its inclusion in PhenQ's formulation supports the product's emphasis on appetite regulation and micronutrient synergy. The updated version of PhenQ also includes InnoSlim®, a proprietary blend of Panax notoginseng and Astragalus membranaceus. Recent studies have framed this ingredient as a potential modulator of AMPK pathways and carbohydrate absorption rates. InnoSlim® is becoming a frequent addition to formulas positioned within blood sugar awareness and metabolic health categories. Additional ingredients such as nopal cactus and L-carnitine fumarate contribute to the formula's nutritional profile. Nopal, a fibrous cactus traditionally consumed in various cultures, has been associated with satiety and lipid-binding activity in digestive contexts. L-carnitine, an amino acid compound found in red meat and plant-based sources, is commonly used in nutritional protocols aimed at supporting energy metabolism and recovery. Collectively, these ingredients reflect a formulation philosophy that prioritizes synergistic activity and scientific credibility over bold outcome promises or single-compound dependence. Section 5 – User Journey Narrative / Market Reception As metabolic health continues to receive attention in digital wellness spaces, public curiosity around multi-action supplements like PhenQ has remained steady. Social media forums, community discussion threads, and independent blogs reflect an ongoing interest in products that aim to simplify the experience of managing appetite, mood, and energy — all without the complications associated with pharmaceutical interventions or overly stimulant-heavy alternatives. What distinguishes PhenQ's market positioning is its communication style, which avoids exaggerated results and instead centers around science-informed transparency. Across various digital channels, users frequently raise questions about ingredient sourcing, manufacturing integrity, and whether a given formula complements modern wellness routines — particularly for those pursuing health improvements without restrictive diet regimens or clinical oversight. The company's updated formulation and messaging strategy appear to resonate with these inquiries. Rather than promoting a singular path to weight loss, the updated formula is structured to reflect broader consumer themes, including the desire for satiety support, energy normalization, and formulation diversity. The addition of ingredients such as InnoSlim® and B-vitamins addresses increasing demand for micronutrient optimization and support for metabolic pathways often disrupted by caloric deficit or lifestyle changes. In discussions around natural supplements, audiences increasingly prioritize how a product fits into a larger picture of emotional consistency and sustainable energy, especially in contrast to 'quick burn' formulations that rely heavily on caffeine or unverified compounds. The fact that PhenQ includes commonly understood ingredients like L-carnitine, magnesium, and caffeine — but in modulated, complementary concentrations — contributes to its positioning as an integrative rather than transformative option. This framing, combined with a formula that does not require a prescription and is manufactured under GMP conditions, continues to support its relevance among consumers seeking nutritional autonomy. Rather than emphasizing a transactional promise of transformation, PhenQ appears to contribute to a more moderate and sustainable public dialogue on wellness supplements that support—rather than replace—healthy lifestyle practices. Interested individuals can find formulation disclosures and regulatory information via PhenQ's official website. Section 6 – Availability and Transparency Statement PhenQ's updated formulation is available through its official platform, where consumers can review detailed ingredient information, third-party sourcing disclosures, and manufacturing standards. The product is manufactured in facilities that meet current Good Manufacturing Practice (cGMP) certification standards in both the United States and United Kingdom, with raw ingredients selected according to internal quality assurance protocols. As part of its transparency commitment, PhenQ provides accessible documentation for its trademarked compounds such as α-Lacys Reset® and InnoSlim®, along with references to publicly available nutritional research supporting the inclusion of individual ingredients. The company emphasizes that its supplement is intended for informational and lifestyle-support purposes only and does not position the product as a treatment or replacement for medical supervision. Individuals interested in metabolic wellness strategies are encouraged to explore educational materials hosted on the PhenQ site, which outline general formulation philosophy, frequently asked questions, and links to peer-reviewed research. No prescription is required for purchase, and the product is available exclusively through the company's designated online retail channels. Section 7 – Final Observations & Industry Context The 2025 update of PhenQ arrives at a time when the supplement industry is undergoing renewed scrutiny and transformation, particularly within the weight management category. As consumer expectations shift from single-purpose diet products to multi-functional wellness solutions, brands are reassessing both how they formulate products and how they communicate ingredient purpose. This evolution marks a broader move away from direct weight loss promises toward formulations that acknowledge the interconnected nature of energy, appetite, and motivation. Across the wellness landscape, ingredients once considered niche—such as alpha-lipoic acid, nopal cactus, and botanical extracts like astragalus—are gaining mainstream attention. The increasing presence of these compounds in consumer conversations suggests a growing interest in plant-based and functional ingredient science, especially when backed by human trials and documented safety profiles. PhenQ's approach reflects a maturing sector that recognizes the importance of transparency, nuanced messaging, and sustainable lifestyle support. Rather than offering a singular solution, the formulation aims to complement a growing range of consumer wellness behaviors, including mindful eating, energy balancing, and non-clinical supplementation. As demand for transparency and scientific literacy rises, the presence of products structured like PhenQ—multi-pathway, non-prescription, and disclosure-focused—signals the industry's broader direction. This includes higher consumer literacy, diversified expectations, and an evolving standard of what constitutes a trustworthy supplement. Section 8 – Public Commentary Theme Summary Public discussions surrounding PhenQ's formulation have generated a range of observations reflecting both interest and critical inquiry. A recurring theme across digital wellness communities is the product's emphasis on combining multiple known ingredients into a single formula, which some individuals view as a time-saving approach to general metabolic support. Others have noted the appeal of stimulant moderation—citing the inclusion of moderate levels of caffeine and an absence of harsher synthetic additives—as aligned with preferences for less disruptive daily routines. Among individuals actively comparing non-prescription supplements, the presence of clinically referenced ingredients such as α-Lacys Reset® and chromium picolinate has been identified as a point of interest. These components, frequently mentioned in scientific literature for their roles in energy metabolism and appetite regulation, are often viewed as more familiar or trusted compared to newer or lesser-known compounds. Conversely, some users have raised questions about the realistic scope of results when using non-clinical supplements. There is ongoing discourse around the limitations of over-the-counter solutions, with particular attention paid to the importance of maintaining lifestyle consistency, including diet and physical activity. This reflects a broader caution in the wellness space—an understanding that no standalone product can substitute for foundational health behaviors. Additionally, public commentary has reflected a desire for more transparent sourcing data, third-party testing disclosures, and clearer long-term usage guidelines. These requests are in line with increasing consumer expectations for traceability and safety, especially in products used over extended periods. Overall, discussion themes suggest that PhenQ is being evaluated primarily for its formulation logic, ingredient familiarity, and alignment with wellness-focused—not outcome-promising—weight management strategies. About PhenQ PhenQ is a U.S.- and U.K.-based wellness brand specializing in non-prescription formulations designed to support metabolic health through ingredient transparency and multi-mechanism nutritional design. Since its initial launch, PhenQ has developed a science-informed product portfolio focused on integrating botanical extracts, essential minerals, and amino acid complexes into accessible, non-clinical supplements. The company's mission centers on empowering individuals to make informed wellness decisions through evidence-aligned formulation and educational transparency. PhenQ does not provide medical treatment or diagnostic services. Its products are not intended to diagnose, treat, cure, or prevent any disease, and should be used only as part of a broader wellness routine that includes professional healthcare consultation where appropriate. Contact: Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash
Business Wire
an hour ago
- Business Wire
QT Imaging to Hold Virtual 2025 Annual Meeting of Stockholders on August 19
NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (OTCQB: QTIH), a medical device company engaged in research, development, and commercialization of innovative body imaging systems, today announced that its 2025 Annual Meeting of Stockholders will be held as a virtual meeting on Tuesday, August 19, 2025, at 1:00 p.m. EDT (10:00 a.m. PDT). Stockholders of record at the close of business on July 16, 2025 shall be entitled to vote at the 2025 Annual Meeting. Information about the virtual meeting webcast and instructions for how stockholders can participate in the 2025 Annual Meeting will be included in the definitive proxy statement to be filed with the Securities and Exchange Commission and will be available on the "Investors" section of QT Imaging's website at About QT Imaging Holdings, Inc. QT Imaging Holdings, Inc. is a public (OTCQB: QTIH) medical device company engaged in research, development, and commercialization of innovative body imaging systems using low frequency sound waves. QT Imaging Holdings, Inc. strives to improve global health outcomes. Its strategy is predicated upon the fact that medical imaging is critical to the detection, diagnosis, and treatment of disease and that it should be safe, affordable, accessible, and centered on the patient's experience. For more information on QT Imaging Holdings, Inc., please visit the company's website at Breast Acoustic CT™ is a trademark of an affiliate of QT Imaging Holdings, Inc. Forward-Looking Statements This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements contain words such as 'will,' and 'expect,' or the negative thereof or comparable terminology, and include (without limitation) statements regarding the date of its annual meeting of stockholders. Forward-looking statements involve certain risks and uncertainties, and actual results may differ materially from those discussed in any such statement. These risks include, but are not limited to: research results from the use of the QT Imaging Breast Acoustic CT Scanner, the ability of QT Imaging Holdings to sell and deploy the QT Imaging Breast Acoustic CT Scanner, the ability to extend product offerings into new areas or products, the ability to commercialize technology, unexpected occurrences that deter the full documentation and 'bring to market' plan for products, trends and fluctuations in the industry, changes in demand and purchasing volume of customers, unpredictability of suppliers, the ability to attract and retain qualified personnel and the ability to move product sales to production levels. Additional factors that could cause actual results to differ are discussed under the heading 'Risk Factors' and in other sections of QT Imaging Holding's filings with the SEC, and in its other current and periodic reports filed or furnished from time to time with the SEC. All forward-looking statements in this press release are made as of the date hereof, based on information available to QT Imaging Holdings as of the date hereof, and QT Imaging Holdings assumes no obligation to update any forward-looking statement.
